,,ii  #aagth ,,congress  #b;d ,session  
,s4 #dege  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,july #bj1     
#bjbb,mr4 ,booker 7for himself and ,mr4 
,paul7 introduced the following bill2   
which was read twice and referred to the
 ,committee on the ,judiciary  ,a ,,bill
  ,to clarify that the ,federal ,right  
to ,try law applies to schedule ,i      
substances for which a phase ,i clinical
 trial has been completed and to provide
 access for eligible patients to such   
substances pursuant to the ,federal     
,right to ,try law4  #a4 ,short title   
,this ,act may be cited as the ,right to
 ,try ,clarification ,act4  #b4         
,findings ,congress finds as follows3   
7#a7 ,the ,trickett ,wendler1 ,frank    
,mongiello1 ,jordan ,mc,linn1 and       
,matthew ,bellina ,right to ,try ,act of
 #bjag 7,public ,law #aae-agf7 was      
enacted in #bjah4  7#b7 ,section #efa;,b
 of the ,federal ,food1 ,drug1 and      
,cosmetic ,act 7#ba ,u4,s4,c4           
#cfj;bbb-#j;a71 as added by the ,act    

described in paragraph 7#a7 7referred to
 in this section as the ,federal ,right 
to ,try law71 does not exclude from the 
application of such law schedule ,i     
substances for which a phase ,i clinical
 trial has been completed4  7#c7        
,multiple schedule ,i drugs have        
progressed through phase ,i clinical    
trials and have been designated by the  
,food and ,drug ,administration as      
breakthrough therapies under section    
#ejf of the ,federal ,food1 ,drug1 and  
,cosmetic ,act 7#ba ,u4,s4,c4 #cef7     
because of preliminary clinical evidence
 indicating that such drugs demonstrate 
substantial improvement over existing   
therapies1 but eligible patients have   
not been permitted access to these drugs
 pursuant to the ,federal ,right to ,try
 law4  #c4 ,amendment to ,federal ,right
 to ,try law ,section #efa;,b7b7 of the 
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cfj;bbb-#j;a7b77 is
 amended by inserting any provision of  
the ,controlled ,substances ,act 7#ba   

,u4,s4,c4 #hja et seq47 that prohibits  
the unauthorized use1 possession1       
distribution1 dispensation1 or          
transportation of an eligible           
investigational drug1 before and parts4